Genomic Health, Inc. EBITDA Margin 2010-2019 | GHDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Genomic Health, Inc. (GHDX) over the last 10 years. The current EBITDA margin for Genomic Health, Inc. as of September 30, 2019 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2019-09-30 |
$0.44B |
$0.07B |
15.61% |
2019-06-30 |
$0.43B |
$0.06B |
14.45% |
2019-03-31 |
$0.41B |
$0.05B |
12.90% |
2018-12-31 |
$0.40B |
$0.04B |
9.37% |
2018-09-30 |
$0.38B |
$0.03B |
7.69% |
2018-06-30 |
$0.36B |
$0.02B |
4.17% |
2018-03-31 |
$0.35B |
$0.01B |
1.43% |
2017-12-31 |
$0.34B |
$0.01B |
1.76% |
2017-09-30 |
$0.34B |
$0.01B |
1.49% |
2017-06-30 |
$0.33B |
$0.00B |
0.90% |
2017-03-31 |
$0.33B |
0 |
0.00% |
2016-12-31 |
$0.33B |
$-0.01B |
-2.13% |
2016-09-30 |
$0.32B |
$-0.01B |
-3.75% |
2016-06-30 |
$0.31B |
$-0.02B |
-4.81% |
2016-03-31 |
$0.30B |
$-0.02B |
-6.98% |
2015-12-31 |
$0.29B |
$-0.03B |
-9.38% |
2015-09-30 |
$0.28B |
$-0.03B |
-10.64% |
2015-06-30 |
$0.28B |
$-0.03B |
-10.83% |
2015-03-31 |
$0.28B |
$-0.02B |
-8.70% |
2014-12-31 |
$0.28B |
$-0.02B |
-5.82% |
2014-09-30 |
$0.28B |
$-0.02B |
-6.91% |
2014-06-30 |
$0.27B |
$-0.01B |
-4.78% |
2014-03-31 |
$0.27B |
$-0.01B |
-4.14% |
2013-12-31 |
$0.26B |
$-0.01B |
-1.91% |
2013-09-30 |
$0.25B |
$0.01B |
2.37% |
2013-06-30 |
$0.25B |
$0.01B |
3.66% |
2013-03-31 |
$0.24B |
$0.01B |
5.42% |
2012-12-31 |
$0.24B |
$0.01B |
5.96% |
2012-09-30 |
$0.23B |
$0.02B |
6.58% |
2012-06-30 |
$0.22B |
$0.02B |
6.79% |
2012-03-31 |
$0.21B |
$0.02B |
7.48% |
2011-12-31 |
$0.21B |
$0.02B |
7.77% |
2011-09-30 |
$0.20B |
$0.01B |
7.00% |
2011-06-30 |
$0.19B |
$0.01B |
7.22% |
2011-03-31 |
$0.19B |
$0.01B |
6.99% |
2010-12-31 |
$0.18B |
$0.01B |
6.21% |
2010-09-30 |
$0.17B |
$0.01B |
5.29% |
2010-06-30 |
$0.16B |
$0.01B |
3.05% |
2010-03-31 |
$0.16B |
0 |
0.00% |
2009-12-31 |
$0.15B |
$-0.00B |
-1.99% |